Free. Unsubscribe any time.
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. filed 12 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 14 transactions and 380,857 shares. None carries the SEC's AFF10B5ONE flag; all 12 name a plan in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-06-12, came on the same day as the one before it (2026-06-12) and reports 3 transactions against 1 in the filing before it.
- The sales it reports total 25,000 shares, 21,645 more than the 3,355 in the filing before it.
- Its 12 plan statements rank 358th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 12 filings on file run from 2025-01-07 to 2026-06-12, and state 6 plan adoption dates, from 2024-03-26 to 2025-12-11.
Trades in ARS Pharmaceuticals, Inc. 14
- Shawver Laura — 2025-01-06 · S · 50,000 shares
- Shawver Laura — 2025-02-03 · S · 50,000 shares
- Shawver Laura — 2025-03-05 · S · 400 shares
- Shawver Laura — 2025-03-06 · S · 49,600 shares
- Karas Eric — 2025-03-20 · S · 10,000 shares
- Shawver Laura — 2025-04-07 · S · 50,002 shares
- Karas Eric — 2025-06-18 · S · 15,000 shares
- Karas Eric — 2025-07-01 · S · 15,000 shares
- Tanimoto Sarina — 2025-08-19 · S · 12,344 shares
- Tanimoto Sarina — 2025-08-20 · S · 37,656 shares
- Lowenthal Richard E — 2025-08-21 · S · 50,000 shares
- Scott Kathleen D. — 2025-08-21 · S · 12,500 shares
Adoption dates in ARS Pharmaceuticals, Inc. 6
- 2024-03-26 — stated in 3 filings
- 2024-08-16 — stated in 4 filings
- 2025-05-15 — stated in 2 filings
- 2025-05-22 — stated in 1 filing
- 2025-12-05 — stated in 1 filing
- 2025-12-11 — stated in 1 filing
Results prints in ARS Pharmaceuticals, Inc. 8
- 2025-01-13
- 2025-03-20
- 2025-05-14
- 2025-08-13
- 2025-11-10
- 2026-03-09
- 2026-05-15
- 2026-08-13
Trades before a print in ARS Pharmaceuticals, Inc. 1
- 0 days before the 2025-03-20 print — 2025-03-20 · S · Karas Eric · 10,000 shares
- 7 days before the 2025-01-13 print — 2025-01-06 · S · Shawver Laura · 50,000 shares
- 14 days before the 2025-03-20 print — 2025-03-06 · S · Shawver Laura · 49,600 shares
- 15 days before the 2025-03-20 print — 2025-03-05 · S · Shawver Laura · 400 shares
- 37 days before the 2025-05-14 print — 2025-04-07 · S · Shawver Laura · 50,002 shares
- 43 days before the 2025-08-13 print — 2025-07-01 · S · Karas Eric · 15,000 shares
- 45 days before the 2025-03-20 print — 2025-02-03 · S · Shawver Laura · 50,000 shares
- 56 days before the 2025-08-13 print — 2025-06-18 · S · Karas Eric · 15,000 shares
- 62 days before the 2026-08-13 print — 2026-06-12 · S · Fitzpatrick Alexander A · 3,355 shares
- 62 days before the 2026-08-13 print — 2026-06-12 · S · Karas Eric · 25,000 shares
- 81 days before the 2025-11-10 print — 2025-08-21 · S · Lowenthal Richard E · 50,000 shares
- 81 days before the 2025-11-10 print — 2025-08-21 · S · Scott Kathleen D. · 12,500 shares
Interval to ARS Pharmaceuticals, Inc.’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 2within 10 days
- 0shortest, days
- 0no later print
- Shawver Laura 2025-01-06 · S · 7 days before the 2025-01-13 print
- Karas Eric 2025-03-20 · S · 0 days before the 2025-03-20 print · Chief Commercial Officer
Adoption dates ARS Pharmaceuticals, Inc. states
- 2024-03-26 in 3 filings
- 2024-08-16 in 4 filings
- 2025-05-15 in 2 filings
- 2025-05-22 in 1 filing
- 2025-12-05 in 1 filing
- 2025-12-11 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 5, 2025”
Reported results dates on file
- 2025-01-13
- 2025-03-20
- 2025-05-14
- 2025-08-13
- 2025-11-10
- 2026-03-09
- 2026-05-15
- 2026-08-13
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.